Signals Group

Signals is a media, research, and advisory platform advancing the future of kidney health. We explore the ideas, innovations, and investments shaping this field and connect the people building what’s next. What began as a newsletter has grown into a trusted hub for insights, expertise, and talent across the kidney care ecosystem. Signals now includes a purpose-built jobs board for mid-to-senior level roles, a curated expert network for advisory and insight engagements, and a growing community platform designed to highlight the stories that drive this work forward. Our readership spans more than 15,000 professionals across 50+ countries, including leaders in industry, investment, academia, advocacy, and government. We’re now tracking over 175 companies from idea to IPO and bringing together top minds across devices, diagnostics, life sciences, value-based care, and beyond to accelerate progress for the 850 million people affected by kidney disease globally. Whether you're launching a product, entering a new market, or preparing to raise capital, Signals can help. Contact us to sponsor a future issue or explore an advisory engagement tailored to your next milestone.